newsfilter
← Latest News
ACCESS Newswire·

InMed Pharmaceuticals (INM): Notable Launches of High-Value Rare Cannabinoids

LONDON, UK / ACCESSWIRE / May 3, 2022 / InMed Pharmaceuticals (INM) continues its transition from a pure-play pharma R&D firm to one also benefiting from commercial sales into the health and wellness market. Product launches of high-value, rare cannabino